CDH12 plays an important role in non-small-cell lung cancer(NSCLC) geneses, resulting from that the mutations of CDH12 and other PRAME family members were equally distributed among tumors of different grades and stages (Bankovic et al., 2010). This evidence concerns the gene CDH12 and non-small cell lung carcinoma.